Eleven million euros to watch muscles at work

A leading European team has won one of the prestigious Synergy Grants from the European Research Council. The researchers aim to show for the first time, molecule by molecule, how our muscles contract, and so gain a better understanding of heart and muscle disease.

 

Our heart beats around 100,000 times a day, without pause, for a whole lifetime. A European research team now sets out to make visible, down to the single molecule, what happens inside its muscle cells. The European Research Council (ERC) is funding the MAROCO ("Mechanism and Regulation of Muscle Contraction") project with 11 million euros over six years. In addition to Stefan Raunser of the Max Planck Institute for Molecular Physiology in Dortmund, Gerhard Hummer of the Max Planck Institute for Biophysics in Frankfurt am Main, and Anne Houdusse-Juillé of the Institut Curie in Paris, Fan Liu—who served as a group leader at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie until the end of October—is also involved. In the future, she will be working at the Research Institute for Molecular Pathology (IMP) in Vienna.

“So far, we have only seen muscle at the molecular level in still images, relaxed or in rigor mortis,” says project coordinator Stefan Raunser. “Now we want to capture it in motion for the first time.” This knowledge is urgently needed. Cardiovascular disease is the leading cause of death worldwide. Many inherited heart and muscle disorders arise because a single component of the muscle machinery is altered.

Rowers in the muscle

Every muscle consists of millions of tiny units called sarcomeres. Inside them, thick and thin protein filaments interlock. The thick filaments, made of myosin, carry hundreds of small heads. Like oar blades, they grip the thin filaments of actin, pull and let go again. The filaments slide past each other, and the muscle shortens.

Calcium gives the starting signal. In resting muscle, many myosin heads park close to their own filament and join in only when needed. The giant protein titin acts as a spring that passes stretch on to the myosin filaments. How all these parts work together remains largely unknown.

Snapshots from working muscle

The team builds on outstanding previous work. Raunser’s group uses cryo-electron tomography, a kind of CT scan inside the electron microscope. With it, the group produced the first high-resolution 3D images from intact muscle tissue, including the myosin filament of the heart. For MAROCO, the team is developing new methods to freeze muscles in the middle of a contraction. This yields snapshots of muscle at work. The four groups complement each other in a unique way. Fan Liu determines which proteins touch each other during contraction. “Many parts of the sarcomere move so much that they blur in the images,” says Liu. “Our chemical crosslinks show where they sit.” Anne Houdusse-Juillé provides atomic-level structures of individual components. “We already know where heart drugs such as mavacamten bind to myosin,” she says. “In the intact sarcomere we will see how they act. That is the basis for more targeted drugs.”

A muscle in the computer

Gerhard Hummer brings all the data together in the computer. “In the end, we want a virtual sarcomere that contracts like a real one,” he says. “It will let us test what damage a single mutation does in the heart.” The team will put the model online as a freely accessible 3D atlas. Research groups worldwide and the pharmaceutical industry can use it to develop new therapies for heart and muscle disease.

Synergy Grants are the ERC’s most highly endowed funding scheme. They go to teams of two to four researchers who work together on questions that no single group could answer.